TCIM
ABMD

TIAA CREF Investment Management’s Abiomed Inc ABMD Stock Holding History

TIAA CREF Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$33.1M Sell
115,933
-52,536
-31% -$17.5M 0.02% 514
2018
Q4 		$54.8M Sell
168,469
-64,289
-28% -$22.3M 0.04% 370
2018
Q3 		$105M Buy
232,758
+53,671
+30% +$21.2M 0.07% 272
2018
Q2 		$73.3M Buy
179,087
+53,722
+43% +$19.5M 0.05% 344
2018
Q1 		$36.5M Sell
125,365
-40,323
-24% -$10.2M 0.02% 534
2017
Q4 		$31.1M Sell
165,688
-24,951
-13% -$4.66M 0.02% 589
2017
Q3 		$32.1M Sell
190,639
-1,920
-1% -$290K 0.02% 582
2017
Q2 		$27.6M Sell
192,559
-16,324
-8% -$2.19M 0.02% 624
2017
Q1 		$26.2M Buy
208,883
+75,292
+56% +$8.73M 0.02% 650
2016
Q4 		$15.1M Sell
133,591
-7,773
-5% -$900K 0.01% 883
2016
Q3 		$18.2K Buy
141,364
+5,549
+4% +$665K 0.01% 815
2016
Q2 		$14.8M Sell
135,815
-43,932
-24% -$4.37M 0.01% 855
2016
Q1 		$17M Buy
179,747
+7,886
+5% +$666K 0.01% 803
2015
Q4 		$15.5M Sell
171,861
-3,157
-2% -$268K 0.01% 853
2015
Q3 		$16.2M Buy
175,018
+24,938
+17% +$2.2M 0.01% 817
2015
Q2 		$9.87M Buy
150,080
+2,770
+2% +$184K 0.01% 1153
2015
Q1 		$10.5M Sell
147,310
-3,000
-2% -$163K 0.01% 1100
2014
Q4 		$5.72M Sell
150,310
-8,863
-6% -$280K ﹤0.01% 1537
2014
Q3 		$3.95M Sell
159,173
-4,392
-3% -$111K ﹤0.01% 1783
2014
Q2 		$4.11M Sell
163,565
-34,805
-18% -$810K ﹤0.01% 1828
2014
Q1 		$5.17M Sell
198,370
-2,720
-1% -$75.2K ﹤0.01% 1582
2013
Q4 		$5.38M Sell
201,090
-1,480
-0.7% -$36.6K ﹤0.01% 1587
2013
Q3 		$3.86M Sell
202,570
-2,844
-1% -$65K ﹤0.01% 1773
2013
Q2 		$4.43M Buy
+205,414
New +$4.13M ﹤0.01% 1615

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TIAA CREF Investment Management's ABMD Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Abiomed Inc (ABMD) stake by 31% in Q1 2019, selling an estimated $17.5M and leaving 115,933 shares worth $33.1M. The position accounts for 0.02% of the portfolio, ranked #514.

TIAA CREF Investment Management first reported a position in ABMD in Q2 2013 and has held it in 24 quarters since. The position peaked at $105M in Q3 2018. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • TIAA CREF Investment Management held 115,933 shares of Abiomed Inc worth $33.1M as of Q1 2019.
  • TIAA CREF Investment Management sold 52,536 Abiomed Inc shares in Q1 2019, an estimated $17.5M.
  • Abiomed Inc made up 0.02% of TIAA CREF Investment Management's portfolio in Q1 2019, its #514 holding.
  • TIAA CREF Investment Management first reported a position in Abiomed Inc in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Abiomed Inc position peaked at $105M in Q3 2018.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.